Pinnacle Wealth Management Advisory Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,025	Closed	-$362K	–	306
2022 Q1	$362K	Buy	4,025 +25	+0.6%	+$2.31K	0.05%	210
2021 Q4	$448K	Hold	4,000	–	–	0.07%	185
2021 Q3	$503K	Hold	4,000	–	–	0.12%	146
2021 Q2	$542K	Hold	4,000	–	–	0.13%	140
2021 Q1	$543K	Sell	4,000 -15	-0.4%	-$2.25K	0.15%	118
2020 Q4	$565K	Buy	4,015 +15	+0.4%	+$1.92K	0.17%	109
2020 Q3	$446K	Hold	4,000	–	–	0.16%	117
2020 Q2	$448K	Buy	+4,000	New	+$394K	0.17%	112
2018 Q4	–	Sell	-5,209	Closed	-$499K	–	179
2018 Q3	$499K	Buy	+5,209	New	+$505K	0.25%	100

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's XBI Position: Q2 2022 in Review

Pinnacle Wealth Management Advisory Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 4,025 shares — an estimated $362K sold.

Pinnacle Wealth Management Advisory Group first reported a position in XBI in Q3 2018 and held it in 9 quarters. The position peaked at $565K in Q4 2020. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Pinnacle Wealth Management Advisory Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Pinnacle Wealth Management Advisory Group sold 4,025 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $362K.
Pinnacle Wealth Management Advisory Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 9 quarters.
Pinnacle Wealth Management Advisory Group's State Street SPDR S&P Biotech ETF position peaked at $565K in Q4 2020.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2022, filed 1 Aug 2022.